1gkc: Difference between revisions
No edit summary |
No edit summary |
||
| Line 24: | Line 24: | ||
[[Category: matrix metalloprotease]] | [[Category: matrix metalloprotease]] | ||
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Oct 30 | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Oct 30 15:14:15 2007'' | ||
Revision as of 16:09, 30 October 2007
|
MMP9-INHIBITOR COMPLEX
OverviewOverview
Matrix metalloproteinases (MMPs) and their inhibitors are important in, connective tissue re-modelling in diseases of the cardiovascular system, such as atherosclerosis. Various members of the MMP family have been shown, to be expressed in atherosclerotic lesions, but MMP9 is consistently seen, in inflammatory atherosclerotic lesions. MMP9 over-expression is, implicated in the vascular re-modelling events preceding plaque rupture, (the most common cause of acute myocardial infarction). Reduced MMP9, activity, either by genetic manipulation or through pharmacological, intervention, has an impact on ventricular re-modelling following, infarction. MMP9 activity may therefore represent a key mechanism in the, pathogenesis of heart failure. We have determined the crystal structure, at 2.3 A ... [(full description)]
About this StructureAbout this Structure
1GKC is a [Single protein] structure of sequence from [Homo sapiens] with CA, ZN and BUM as [ligands]. Active as [Gelatinase B], with EC number [3.4.24.35]. Structure known Active Site: BUA. Full crystallographic information is available from [OCA].
ReferenceReference
Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor., Rowsell S, Hawtin P, Minshull CA, Jepson H, Brockbank SM, Barratt DG, Slater AM, McPheat WL, Waterson D, Henney AM, Pauptit RA, J Mol Biol. 2002 May 24;319(1):173-81. PMID:12051944
Page seeded by OCA on Tue Oct 30 15:14:15 2007